Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

ESMO Immuno-Oncology Congress 2024

Start date: 11 Dec 2024
End date: 13 Dec 2024
Location: Geneva, Switzerland

Save the date for the ESMO Immuno-Oncology Congress 2024, taking place from 11 until 13 December 2024 in Geneva, Switzerland, and online.

This international event provides an advanced educational programme and showcases recent scientific developments in this promising and fast-evolving field.

From the basics of immunotherapies to the latest research results; from understanding different treatment options to the management of toxicities and interpretation of new data, this event will cater to the diverse needs of oncology stakeholders with an interest in this topical field of cancer treatment.

Take part in this meeting to learn, share your research and expertise and connect with the stakeholders that are making a difference in the field.

ESMO Immuno-Oncology 2024 Scientific Committee Co-Chairs:

Michele Maio
Siena, Italy

“A great opportunity to share our ideas and the results of our research”

Aurélien Marabelle
Villejuif, France

“An event to access the most recent discoveries in the field”

Inge Marie Svane
Copenhagen, Denmark

“This event gathers key stakeholders, to guarantee that this field moves forward”

Call for YO Clinical cases

#ESMOImmuno24: All #YoungOncologists and Trainees can submit their clinical case in one of the topics below for their chance to present and discuss it in Geneva:

Biomarker based immunotherapy in rare tumors
Management of ICANS (Immune effector cell-associated neurotoxicity syndrome) with cell therapy or bispecifics

Successful applicants will be invited to present their cases during the YO Clinical Case Discussion session planned on 13 December in Geneva.

Deadline: 27 October 2024

Submit your clinical case